Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Pharmacoeconomics|November 21, 2014
Resource modelling: the missing piece of the HTA jigsaw?Praveen Thokala, Simon Dixon, Beate Jahn
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 30, 2010
Tutorial in medical decision modeling incorporating waiting lines and queues using discrete event simulationBeate Jahn, Engelbert Theurl, Uwe Siebert, et al.
Clinical Pediatrics|August 9, 2006
C-reactive protein and leukocytes do not reliably indicate severity of influenza a infection in childhoodMonika Edelbauer, Reinhard Würzner, Beate Jahn, et al.
Applied Health Economics and Health Policy|February 11, 2017
Cost-Effectiveness Models in Breast Cancer Screening in the General Population: A Systematic ReviewIrmgard C Schiller-Frühwirth, Beate Jahn, Marjan Arvandi, et al.
International Journal of Technology Assessment in Health Care|December 18, 2024
Evaluations of digital public health interventions in the WHO Southeast Asia Region: a systematic literature reviewNachiket Gudi, Elstin Anbu Raj, Beate Jahn, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 14, 2025
Life Expectancy Predicted by Decision-Analytic Models Evaluating Screening for Prostate, Lung, Breast, and Colorectal Cancer: A Systematic Review Focusing on Competing Mortality RisksChristin Henning, Gaby Sroczynski, Lára Hallsson, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 1, 2009
Capacity constraints and cost-effectiveness: a discrete event simulation for drug-eluting stentsBeate Jahn, Karl Peter Pfeiffer, Engelbert Theurl, et al.
Plos One|August 28, 2019
Why should we apply ABM for decision analysis for infectious diseases?-An example for dengue interventionsFlorian Miksch, Beate Jahn, Kurt Junshean Espinosa, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 2, 2017
The Long-Term Effectiveness and Cost Effectiveness of Organized versus Opportunistic Screening for Breast Cancer in AustriaIrmgard Schiller-Fruehwirth, Beate Jahn, Patrick Einzinger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 9, 2026
Cost-effectiveness Analysis of Xpert MTB/RIF Ultra for the Diagnosis of HIV-Associated Tuberculous MeningitisOmar K Siddiqi, Beate Jahn, Ursula Rochau, et al.
Pageof 7